{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:58:46Z","timestamp":1794013126611,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Patients with bladder cancer (BCa) have a poor prognosis and are prone to metastasis. Deficiency of 1,25-dihydroxyvitamin D3 (VD) is associated with increased incidence and decreased survival in various tumors. Herein, we aimed to examine the effect of VD combined with cisplatin (DDP) on the proliferation and apoptosis of BCa cells and elucidate the underlying mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>T24 and 5637 BCa cell lines were treated with different concentrations of DDP and VD to assess the effects of various doses of DDP and VD on BCa cytotoxicity and determine the appropriate combination dose. T24 cells were treated with DDP and VD to assess the effects of the drug combination on cell proliferation, apoptosis, cycling, Warburg effect, and DDP sensitivity. In addition, cells were treated with DDP, VD, pyruvic acid sodium (PAS), or SC79 to determine the effect of VD on the sensitivity of BCa cells to DDP mediated by inhibiting the Warburg effect through AKT\/mTOR signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>VD and DDP inhibited BCa cell proliferation; promoted apoptosis; downregulated the protein expression of GLUT1, LDHA, HK2, c-Myc, MRP1, and P-gp; and upregulated the expression of p-mTOR protein. VD combined with DDP reversed the effects of PAS on cells and promoted apoptosis by inhibiting the cellular Warburg effect. In addition, VD combined with DDP activated the AKT\/mTOR pathway and reversed the effects of SC79 on cell proliferation and the Warburg effect.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>VD could promote apoptosis and enhance DDP sensitivity in BCa cells by inhibiting the Warburg effect via the AKT\/mTOR pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-025-01994-2","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T03:15:28Z","timestamp":1765768528000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Vitamin D promotes apoptosis and enhances cisplatin sensitivity in bladder cancer cells by inhibiting the Warburg effect through the AKT\/mTOR pathway"],"prefix":"10.1186","volume":"26","author":[{"given":"Jian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"1994_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Medicina (B Aires). 2021. https:\/\/doi.org\/10.3390\/medicina57080749.","journal-title":"Medicina (B Aires)"},{"issue":"8","key":"1994_CR2","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1007\/s00345-019-02984-4","volume":"38","author":"A Richters","year":"2020","unstructured":"Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895\u2013904. https:\/\/doi.org\/10.1007\/s00345-019-02984-4.","journal-title":"World J Urol"},{"key":"1994_CR3","doi-asserted-by":"publisher","unstructured":"Colombel M, Soloway M, Akaza H, et al. Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer. European Urology Supplements. 2008;7(10):618\u2013626. https:\/\/doi.org\/10.1016\/j.eursup.2008.08.002.","DOI":"10.1016\/j.eursup.2008.08.002"},{"issue":"1","key":"1994_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01517-9","volume":"21","author":"ZD Shi","year":"2022","unstructured":"Shi ZD, Hao L, Han XX, Wu ZX, Pang K, Dong Y, et al. Targeting HNRNPU to overcome cisplatin resistance in bladder cancer. Mol Cancer. 2022;21(1):37. https:\/\/doi.org\/10.1186\/s12943-022-01517-9.","journal-title":"Mol Cancer"},{"issue":"8","key":"1994_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41585-019-0208-0","volume":"16","author":"C Alifrangis","year":"2019","unstructured":"Alifrangis C, McGovern U, Freeman A, Powles T, Linch M. Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol. 2019;16(8):465\u201383. https:\/\/doi.org\/10.1038\/s41585-019-0208-0.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"1994_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02320-7","volume":"8","author":"D Liu","year":"2017","unstructured":"Liu D, Abbosh P, Keliher D, Reardon B, Miao D, Mouw K, et al. Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer. Nat Commun. 2017;8(1):2193. https:\/\/doi.org\/10.1038\/s41467-017-02320-7.","journal-title":"Nat Commun"},{"issue":"2","key":"1994_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009.","journal-title":"Cancer Cell"},{"issue":"3","key":"1994_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/aja.aja_14_18","volume":"20","author":"DL Trump","year":"2018","unstructured":"Trump DL, Aragon-Ching JB. Vitamin D in prostate cancer. Asian J Androl. 2018;20(3):244\u201352. https:\/\/doi.org\/10.4103\/aja.aja_14_18.","journal-title":"Asian J Androl"},{"key":"1994_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14183867","author":"K Piatek","year":"2022","unstructured":"Piatek K, Schepelmann M, Kallay E. The effect of vitamin D and its analogs in ovarian cancer. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14183867.","journal-title":"Nutrients"},{"key":"1994_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.biopha.2018.10.102","volume":"109","author":"N Fathi","year":"2019","unstructured":"Fathi N, Ahmadian E, Shahi S, Roshangar L, Khan H, Kouhsoltani M, et al. Role of vitamin D and vitamin D receptor (VDR) in oral cancer. Biomed Pharmacother. 2019;109:391\u2013401. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.102.","journal-title":"Biomed Pharmacother"},{"key":"1994_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061798","author":"M Negri","year":"2020","unstructured":"Negri M, Gentile A, de Angelis C, Mont\u00f2 T, Patalano R, Colao A, et al. Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells. Nutrients. 2020. https:\/\/doi.org\/10.3390\/nu12061798.","journal-title":"Nutrients"},{"issue":"2","key":"1994_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/SMJ.0b013e3182824d00","volume":"106","author":"AN Peiris","year":"2013","unstructured":"Peiris AN, Bailey BA, Manning T. Relationship of vitamin D monitoring and status to bladder cancer survival in veterans. South Med J. 2013;106(2):126\u201330. https:\/\/doi.org\/10.1097\/SMJ.0b013e3182824d00.","journal-title":"South Med J"},{"issue":"5","key":"1994_CR13","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1159\/000438534","volume":"37","author":"H Zhang","year":"2015","unstructured":"Zhang H, Zhang H, Wen X, Zhang Y, Wei X, Liu T. Vitamin D deficiency and increased risk of bladder carcinoma: a meta-analysis. Cell Physiol Biochem. 2015;37(5):1686\u201392. https:\/\/doi.org\/10.1159\/000438534.","journal-title":"Cell Physiol Biochem"},{"issue":"5","key":"1994_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3892\/ijmm.2014.1664","volume":"33","author":"A Bao","year":"2014","unstructured":"Bao A, Li Y, Tong Y, Zheng H, Wu W, Wei C. 1,25-dihydroxyvitamin D\u2083 and cisplatin synergistically induce apoptosis and cell cycle arrest in gastric cancer cells. Int J Mol Med. 2014;33(5):1177\u201384. https:\/\/doi.org\/10.3892\/ijmm.2014.1664.","journal-title":"Int J Mol Med"},{"issue":"20","key":"1994_CR15","doi-asserted-by":"publisher","first-page":"33064","DOI":"10.18632\/oncotarget.16524","volume":"8","author":"K Minami","year":"2017","unstructured":"Minami K, Taniguchi K, Sugito N, Kuranaga Y, Inamoto T, Takahara K, et al. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells. Oncotarget. 2017;8(20):33064\u201377. https:\/\/doi.org\/10.18632\/oncotarget.16524.","journal-title":"Oncotarget"},{"key":"1994_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","volume":"45","author":"F Massari","year":"2016","unstructured":"Massari F, Ciccarese C, Santoni M, Iacovelli R, Mazzucchelli R, Piva F, et al. Metabolic phenotype of bladder cancer. Cancer Treat Rev. 2016;45:46\u201357. https:\/\/doi.org\/10.1016\/j.ctrv.2016.03.005.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"1994_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2006.04.023","volume":"9","author":"VR Fantin","year":"2006","unstructured":"Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9(6):425\u201334. https:\/\/doi.org\/10.1016\/j.ccr.2006.04.023.","journal-title":"Cancer Cell"},{"issue":"1","key":"1994_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cels.2018.06.003","volume":"7","author":"LB Tanner","year":"2018","unstructured":"Tanner LB, Goglia AG, Wei MH, Sehgal T, Parsons LR, Park JO, White E, Toettcher JE, Rabinowitz JD. Four key steps control glycolytic flux in mammalian cells. Cell Syst. 2018;7(1):49\u2013e6248. https:\/\/doi.org\/10.1016\/j.cels.2018.06.003.","journal-title":"Cell Syst"},{"issue":"9","key":"1994_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/life11090963","volume":"11","author":"CY Huang","year":"2021","unstructured":"Huang CY, Weng YT, Li PC, Hsieh NT, Li CI, Liu HS, et al. Calcitriol suppresses Warburg effect and cell growth in human colorectal cancer cells. Life. 2021;11(9):963. https:\/\/doi.org\/10.3390\/life11090963.","journal-title":"Life"},{"issue":"18","key":"1994_CR20","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1097\/wnr.0000000000001156","volume":"29","author":"W Huang","year":"2018","unstructured":"Huang W, Ding X, Ye H, Wang J, Shao J, Huang T. Hypoxia enhances the migration and invasion of human glioblastoma U87 cells through PI3K\/Akt\/mTOR\/HIF-1\u03b1 pathway. Neuroreport. 2018;29(18):1578\u201385. https:\/\/doi.org\/10.1097\/wnr.0000000000001156.","journal-title":"Neuroreport"},{"issue":"1","key":"1994_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-018-0730-6","volume":"37","author":"YH Yeh","year":"2018","unstructured":"Yeh YH, Hsiao HF, Yeh YC, Chen TW, Li TK. Inflammatory interferon activates HIF-1\u03b1-mediated epithelial-to-mesenchymal transition via PI3K\/AKT\/mTOR pathway. J Exp Clin Cancer Res. 2018;37(1):70. https:\/\/doi.org\/10.1186\/s13046-018-0730-6.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6 Suppl 4","key":"1994_CR22","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.5489\/cuaj.1202","volume":"3","author":"P Black","year":"2009","unstructured":"Black P, So A. Perioperative chemotherapy for muscle-invasive bladder cancer. Can Urol Assoc J. 2009;3(6 Suppl 4):S223\u2013227. https:\/\/doi.org\/10.5489\/cuaj.1202.","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"1994_CR23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.eururo.2011.03.023","volume":"59","author":"A Stenzl","year":"2011","unstructured":"Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011;59(6):1009\u201318. https:\/\/doi.org\/10.1016\/j.eururo.2011.03.023.","journal-title":"Eur Urol"},{"issue":"20","key":"1994_CR24","doi-asserted-by":"publisher","first-page":"7656","DOI":"10.26355\/eurrev_202210_30042","volume":"26","author":"YC Di","year":"2022","unstructured":"Di YC, Zhang ZH, Sun YP, Song J. Vitamin D3 sensitizes resistant human bladder cancer cells to cisplatin by regulating Sirtuin 1 gene expression. Eur Rev Med Pharmacol Sci. 2022;26(20):7656\u201366. https:\/\/doi.org\/10.26355\/eurrev_202210_30042.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"1994_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrc2196","volume":"7","author":"KK Deeb","year":"2007","unstructured":"Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684\u2013700. https:\/\/doi.org\/10.1038\/nrc2196.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"1994_CR26","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.18632\/oncotarget.1494","volume":"4","author":"JW Hsu","year":"2013","unstructured":"Hsu JW, Yin PN, Wood R, Messing J, Messing E, Lee YF. 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer. Oncotarget. 2013;4(12):2397\u2013406. https:\/\/doi.org\/10.18632\/oncotarget.1494.","journal-title":"Oncotarget"},{"key":"1994_CR27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.semcancer.2020.05.018","volume":"79","author":"C Carlberg","year":"2022","unstructured":"Carlberg C, Mu\u00f1oz A. An update on vitamin D signaling and cancer. Semin Cancer Biol. 2022;79:217\u201330. https:\/\/doi.org\/10.1016\/j.semcancer.2020.05.018.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"1994_CR28","doi-asserted-by":"publisher","first-page":"164","DOI":"10.14715\/cmb\/2023.69.7.26","volume":"69","author":"Y Liu","year":"2023","unstructured":"Liu Y, Meng X, Zhang X, He L, Wang Y. Vitamin D inhibits colorectal cancer cell Proliferation, migration and invasion via downregulating the Notch1 pathway. Cell Mol Biol (Noisy-le-grand). 2023;69(7):164\u20137. https:\/\/doi.org\/10.14715\/cmb\/2023.69.7.26.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"12","key":"1994_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2177-x","volume":"10","author":"Z Huang","year":"2019","unstructured":"Huang Z, Zhang Y, Li H, Zhou Y, Zhang Q, Chen R, et al. Vitamin D promotes the cisplatin sensitivity of oral squamous cell carcinoma by inhibiting LCN2-modulated NF-\u03baB pathway activation through RPS3. Cell Death Dis. 2019;10(12):936. https:\/\/doi.org\/10.1038\/s41419-019-2177-x.","journal-title":"Cell Death Dis"},{"issue":"3","key":"1994_CR30","first-page":"1372","volume":"12","author":"Z Xu","year":"2022","unstructured":"Xu Z, Shao J, Zheng C, Cai J, Li B, Peng X, et al. The E3 ubiquitin ligase RBCK1 promotes the invasion and metastasis of hepatocellular carcinoma by destroying the PPAR\u03b3\/PGC1\u03b1 complex. Am J Cancer Res. 2022;12(3):1372\u201392.","journal-title":"Am J Cancer Res"},{"issue":"2","key":"1994_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15384101.2022.2112006","volume":"22","author":"P Bao","year":"2023","unstructured":"Bao P, Li P, Zhou X, Zhang H, You S, Xu Z, et al. SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt\/\u03b2-catenin signaling pathway. Cell Cycle. 2023;22(2):229\u201341. https:\/\/doi.org\/10.1080\/15384101.2022.2112006.","journal-title":"Cell Cycle"},{"key":"1994_CR32","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","volume":"27","author":"SY Lunt","year":"2011","unstructured":"Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441\u201364. https:\/\/doi.org\/10.1146\/annurev-cellbio-092910-154237.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"9","key":"1994_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1101\/gad.1067003","volume":"17","author":"PC Fernandez","year":"2003","unstructured":"Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, et al. Genomic targets of the human c-Myc protein. Genes Dev. 2003;17(9):1115\u201329. https:\/\/doi.org\/10.1101\/gad.1067003.","journal-title":"Genes Dev"},{"issue":"21","key":"1994_CR34","doi-asserted-by":"publisher","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479\u201383. 10.1158\/1078\u2009\u2013\u20090432.Ccr-09-0889.","journal-title":"Clin Cancer Res"},{"key":"1994_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00274","volume":"10","author":"S Zuo","year":"2020","unstructured":"Zuo S, Wu L, Wang Y, Yuan X. Long non-coding RNA MEG3 activated by vitamin D suppresses glycolysis in colorectal cancer via promoting c-Myc degradation. Front Oncol. 2020;10:274. https:\/\/doi.org\/10.3389\/fonc.2020.00274.","journal-title":"Front Oncol"},{"issue":"1","key":"1994_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00367-3","volume":"10","author":"Y Xu","year":"2022","unstructured":"Xu Y, Hino C, Baylink DJ, Xiao J, Reeves ME, Zhong JF, et al. Vitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia. Biomark Res. 2022;10(1):16. https:\/\/doi.org\/10.1186\/s40364-022-00367-3.","journal-title":"Biomark Res"},{"issue":"1","key":"1994_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.2174\/1568009621666210729100300","volume":"22","author":"S Yiyan","year":"2022","unstructured":"Yiyan S, Yang S, Li D, Li W. Vitamin D affects the Warburg effect and stemness maintenance of non- small-cell lung cancer cells by regulating the PI3K\/AKT\/mTOR signaling pathway. Curr Cancer Drug Targets. 2022;22(1):86\u201395. https:\/\/doi.org\/10.2174\/1568009621666210729100300.","journal-title":"Curr Cancer Drug Targets"},{"key":"1994_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2019.03.006","volume":"59","author":"W Jiang","year":"2019","unstructured":"Jiang W, Ji M. Receptor tyrosine kinases in PI3K signaling: the therapeutic targets in cancer. Semin Cancer Biol. 2019;59:3\u201322. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.006.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"1994_CR39","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2174\/156800910791517172","volume":"10","author":"L Ciuffreda","year":"2010","unstructured":"Ciuffreda L, Di Sanza C, Incani UC, Milella M. The mTOR pathway: a new target in cancer therapy. Curr Cancer Drug Targets. 2010;10(5):484\u201395. https:\/\/doi.org\/10.2174\/156800910791517172.","journal-title":"Curr Cancer Drug Targets"},{"issue":"10","key":"1994_CR40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/1535370220987524","volume":"246","author":"H Lim","year":"2021","unstructured":"Lim H, Lee H, Lim Y. Effect of vitamin D(3) supplementation on hepatic lipid dysregulation associated with autophagy regulatory AMPK\/Akt-mTOR signaling in type 2 diabetic mice. Exp Biol Med (Maywood). 2021;246(10):1139\u201347. https:\/\/doi.org\/10.1177\/1535370220987524.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1994_CR41","doi-asserted-by":"publisher","unstructured":"Almaimani RA, Aslam A, Ahmad J, El-Readi MZ, El-Boshy ME, Abdelghany AH, Idris S, Alhadrami M, Althubiti M, Almasmoum HA, et al. In vivo and in vitro enhanced tumoricidal effects of Metformin, active vitamin D(3), and 5-Fluorouracil triple therapy against colon cancer by modulating the PI3K\/Akt\/PTEN\/mTOR network. Cancers (Basel). 2022;14(6). https:\/\/doi.org\/10.3390\/cancers14061538.","DOI":"10.3390\/cancers14061538"},{"issue":"3","key":"1994_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.bbrc.2018.12.004","volume":"508","author":"DU Kim","year":"2019","unstructured":"Kim DU, Kwak B, Kim SW. Phosphodiesterase 4B is an effective therapeutic target in colorectal cancer. Biochem Biophys Res Commun. 2019;508(3):825\u201331. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.004.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1994_CR43","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11033-022-08044-2","volume":"50","author":"\u00d6 \u00d6zgen","year":"2023","unstructured":"\u00d6zgen \u00d6, \u00d6zen Ero\u011flu G, K\u00fc\u00e7\u00fckh\u00fcseyin \u00d6, Akdeniz N, Hepokur C, Kuruca S, et al. Vitamin D increases the efficacy of cisplatin on bladder cancer cell lines. Mol Biol Rep. 2023;50(1):697\u2013706. https:\/\/doi.org\/10.1007\/s11033-022-08044-2.","journal-title":"Mol Biol Rep"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01994-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01994-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01994-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:30:00Z","timestamp":1781627400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-025-01994-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1994"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01994-2","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"17 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}